- Home
- BBW vs SANA Comparison
BBW vs SANA Comparison
Compare BBW & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBW
- SANA
- Stock Information
- Founded
- BBW 1997
- SANA 2018
- Country
- BBW United States
- SANA United States
- Employees
- BBW N/A
- SANA N/A
- Industry
- BBW Recreational Games/Products/Toys
- SANA Medicinal Chemicals and Botanical Products
- Sector
- BBW Consumer Discretionary
- SANA Health Care
- Exchange
- BBW Nasdaq
- SANA Nasdaq
- Market Cap
- BBW 590.7M
- SANA 522.4M
- IPO Year
- BBW 2004
- SANA 2021
- Fundamental
- Price
- BBW $39.54
- SANA $3.17
- Analyst Decision
- BBW Strong Buy
- SANA Strong Buy
- Analyst Count
- BBW 3
- SANA 4
- Target Price
- BBW $54.33
- SANA $13.00
- AVG Volume (30 Days)
- BBW 291.5K
- SANA 16.6M
- Earning Date
- BBW 03-13-2025
- SANA 02-27-2025
- Dividend Yield
- BBW 2.08%
- SANA N/A
- EPS Growth
- BBW 8.16
- SANA N/A
- EPS
- BBW 3.79
- SANA N/A
- Revenue
- BBW $495,235,000.00
- SANA N/A
- Revenue This Year
- BBW $2.53
- SANA N/A
- Revenue Next Year
- BBW $2.59
- SANA N/A
- P/E Ratio
- BBW $10.09
- SANA N/A
- Revenue Growth
- BBW 2.76
- SANA N/A
- 52 Week Low
- BBW $21.60
- SANA $1.52
- 52 Week High
- BBW $48.23
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- BBW 41.12
- SANA 52.92
- Support Level
- BBW $41.48
- SANA $2.91
- Resistance Level
- BBW $44.79
- SANA $3.65
- Average True Range (ATR)
- BBW 1.61
- SANA 0.42
- MACD
- BBW -0.07
- SANA -0.05
- Stochastic Oscillator
- BBW 22.05
- SANA 31.68
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.